Within the framework of this model, bone-metastatic tumor cells secrete factors, such as the receptor activator of nuclear factor kappa-B ligand (RANKL), the parathyroid hormone-related protein (PTHrP), or CTGF, which stimulate osteoblasts and osteoclasts. Here, PTHLH is linked to neoplasm.